The $112.5 million in operating losses more than doubled from FY 2011, when they reached $51.8 million. The net loss of $37.8 million also diverged greatly from the $20.4 million in profit recorded in FY 2011.
A silver lining for West Penn was that it recorded $37.8 million in profit in the fourth quarter of 2012. That total is still down 7 percent from the fourth quarter of 2011, but it still helped offset an otherwise tumultuous financial year.
Last week, Fitch Ratings downgraded West Penn’s revenue bonds to “CCC” from “B+”, saying the multi-notch downgrade was a direct result of the health system’s failed merger negotiations with health insurer Highmark.
Other operating results from West Penn’s FY 2012 included a 6.4 percent drop in inpatient discharges and a 2.3 percent decline in total revenue, from $1.6 billion in 2011 to $1.56 billion in 2012.
More Articles on West Penn Allegheny Health System:
Fitch Downgrades West Penn Bonds to “CCC”
Highmark Offered West Penn $125M to File for Bankruptcy
Highmark CEO: West Penn Bankruptcy Was Strategy to Boost Odds of Regulatory Approval
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
